Related Experiment Video
Updated: Apr 24, 2026

Isolation of Small Noncoding RNAs from Human Serum
Published on: June 19, 2014
Distribution profiling of circulating microRNAs in serum
Jonathan Ashby1, Kenneth Flack, Luis A Jimenez
1Department of Chemistry; ‡Program in Biomedical Sciences; §Department of Statistics, University of California, Riverside , Riverside, California 92521, United States.
Abstract:
Circulating microRNAs (miRNAs) are potential biomarkers useful in cancer diagnosis. They have been found to be bound to various carriers like proteins, lipoprotein particles, and exosomes. It is likely that only miRNAs in particular carriers, but not the overall quantity, are directly related to cancer development. Herein, we developed a method for rapid separation of different miRNA carriers in serum using asymmetrical flow field flow fractionation (AF4). Sera from two healthy individuals (control) or from two cancer patients (case) were fractionated. Six fractions enriching different types of miRNA carriers, such as the lipoprotein particles and exosomes, were collected. The quantities of eight selected miRNAs in each fraction were obtained by RT-qPCR to yield their distribution profiles among the carriers. Larger changes in miRNA quantity between the control and the case were detected in the fractionated results compared to the sum values. Statistical analysis on the distribution profiles also proved that, the quantities of 4 miRNAs within particular fractions showed significant difference between the controls and the cases. On the contrary, if the overall quantity of the miRNA was subject to the same statistical analysis, only 2 miRNAs exhibited significant difference. Moreover, principle component analysis revealed good separation between the controls and the cases with the fractionated miRNA amounts. All in all, we have demonstrated that, our method enables comprehensive screening of the distribution of circulating miRNAs in the carriers. The obtained distribution profile enlarges the miRNA expression difference between healthy individuals and cancer patients, facilitating the discovery of specific miRNA biomarkers for cancer diagnosis.
Insights
Analyzing circulating microRNAs (miRNAs) in serum carriers reveals distinct cancer biomarker profiles. This method enhances cancer diagnosis by differentiating miRNA distribution in exosomes and lipoprotein particles.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Circulating microRNAs (miRNAs) are promising cancer biomarkers.
- miRNAs are transported via carriers like proteins, lipoproteins, and exosomes.
- The distribution of miRNAs within these carriers, not just total quantity, may correlate with cancer.
Purpose of the Study:
- To develop a method for separating serum miRNA carriers.
- To analyze miRNA distribution profiles in healthy individuals versus cancer patients.
- To identify specific miRNA carriers as potential cancer biomarkers.
Main Methods:
- Asymmetrical flow field flow fractionation (AF4) was used to separate serum miRNA carriers.
- Six fractions enriched with different carriers (lipoproteins, exosomes) were collected.
- Reverse transcription quantitative polymerase chain reaction (RT-qPCR) quantified eight selected miRNAs in each fraction.
Main Results:
- Fractionated miRNA analysis revealed larger quantity changes between controls and cancer patients compared to total miRNA levels.
- Statistical analysis showed significant differences in 4 miRNAs within specific fractions between groups.
- Principal component analysis demonstrated clear separation between control and cancer groups based on fractionated miRNA amounts.
Conclusions:
- The developed AF4 method effectively screens circulating miRNA distribution in serum carriers.
- Analyzing miRNA distribution profiles enhances the detection of differences between healthy and cancer states.
- This approach facilitates the discovery of specific miRNA biomarkers for improved cancer diagnosis.
Related Concept Videos
MicroRNAs
MicroRNAs

